the World Health Organization. Meeting participants concluded that influenza remains a significant threat especially in high-risk groups (children under-5, elderly, pregnant women and immunosuppressed individuals) in the MENA-ISN region. Additional funding and planning are required by member countries to contain this threat. Future meetings will need to focus on creative and innovative ways to inform policy and initiatives for vaccination, surveillance and management of influenza-related morbidity and mortality especially among the most vulnerable groups of the population. • Improve awareness and knowledge of influenza burden through effective communication, education and training;
• Strengthen evidence base through surveillance and research;
• Reduce the incidence of infection through effective prevention measures;
• Increase influenza vaccine uptake and introduction into the national immunization programmes;
• Develop the economic case for sustainable investment of National Plans.
The purpose of this paper was to report on the current situation of influenza surveillance and action plans to move forward in MENA- Regarding influenza vaccines, developing long-term plans for the use of seasonal influenza vaccines at least among high-risk groups, providing/increasing funding for vaccination by governments and setting-up vaccination campaigns were reported as the main actions to increase vaccine uptake.
| INFLUENZ A PROG R AMME IN E A S TERN MEDITERR ANE AN REG ION

TA B L E 2 Action plan in MENA-ISN countries
Country
Surveillance
Vaccination
Social mobilization
Advocacy and policy
Algeria
countries, namely Afghanistan, Bahrain, Egypt, Iran, Iraq, Jordan, Kuwait, Lebanon, Morocco, Occupied Palestinian Territory, Oman
| COUNTRY S ITUATI ON: AC TI ON S ACHIE VED AND FUTURE OBJEC TIVE S
In addition to the lack of adequate funding to procure influenza vaccines, poor awareness in the public and HCPs about influenza/ vaccine, vaccine hesitancy, absence of clear messages and social mobilization could also contribute to low vaccination coverage in MENA region. Several programmes on education of the community and HCPs are currently ongoing, but more still needs to be done.
Finally, influenza burden (ie morbidity, mortality, loss of working hours) is not well described. More research to clearly estimate the economic burden of influenza and cost of "inaction," to generate new evidence on influenza virus circulation and disease burden can serve as the basis to increase uptake and coverage of seasonal influenza vaccines and to guide measures for pandemic influenza.
The MENA-ISN roadmap is now available to help achieving the network's goals.
| D ISCUSS I ON AND CON CLUD ING REMARK S
Emerging infectious diseases are a major public health problem in the EMR region. Besides, more than half of the 22 countries of the EMR are affected by acute or protracted complex emergencies. Elderly individuals are also at high risk of influenza-related hospitalization and death. 6, 7 Frailty is defined as "a state of increased vulnerability to poor resolution of homoeostasis after a stressor event", which increases the risk of adverse outcomes, 8 and represents a new way to think about vulnerability to influenza 9, 10 that can be used in the MENA region for at-risk individuals. For example, frailty has been studied in influenza surveillance in Canada, where a frailty index based on a Comprehensive Geriatric Assessment has been found to impact estimates of influenza vaccine effectiveness and outcomes of hospitalization with influenza illness. 9 Given that frailty can be measured in different ways, work is ongoing to identify and validate brief measures of frailty such as the Clinical Frailty Scale which may be more readily implemented in resource-diverse settings. hospitalizations due to influenza-related complications. 15 Compared with standard-dose influenza vaccine, high-dose vaccine was also found to reduce hospital admission with respiratory illness [16] [17] [18] and to be cost-saving. 19, 20 Finally, a recombinant influenza vaccine has been shown to provide a better protection in older adults than the standard quadrivalent, inactivated influenza vaccine. 21 At present, the availability of these newer vaccine products is limited in many settings, and where available, they may be cost-prohibitive. With this in mind, implementing a realistic vaccination strategy with available product in order to improve influenza vaccine coverage should be considered as the first-line strategy with whatever influenza vaccine available in a given country.
In summary, despite enhanced influenza surveillance systems, a higher number of NICs that actively perform influenza virus typing and more available information on influenza burden in the region, the current situation is not satisfactory. Key challenges for the future are sustainability, good quality data and more private- Dissemination of surveillance and disease burden data through publications and effective communication tools will help to push health authorities in favour of official recommendations for influenza vaccination.
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